Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Q2 Earnings: Merger Costs Weigh on Profit Ahead of Aug. 5 Vote

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$35.315
Mkt Cap
$7.558B
52W Low
$24.937
52W High
$35.98
52W Position info
42% above low
Off High info
1.8% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

AXTA sits 42% above its 52-week low of $24.937 on light trading volume (0.2× avg).

Summary

Axalta reported Q2 2026 net income of $89 million ($0.41 diluted EPS) on sales of $1.35 billion, with $35 million in merger costs weighing on profits. The shareholder vote on the AkzoNobel merger is set for August 5, 2026.


Key Events · Earnings and Guidance · AXTA

  • Q2 Earnings Hit by Merger Costs

    Net income fell to $89M ($0.41 diluted EPS) from $109M a year ago, as $35M in merger-related costs and a higher tax rate (24.7% vs. 23.2%) offset a 3.1% sales increase to $1.35B.

  • Merger Vote Set for August 5

    Shareholders will vote on the all-stock AkzoNobel merger next week. The deal, amended twice most recently on July 23, would create a dual-headquartered coatings giant.

  • Debt Prepayment Strengthens Balance Sheet

    Axalta prepaid $125M of its 2029 Dollar Term Loans, reducing total borrowings to $3.07B. The $500M 2027 Senior Notes remain classified as current, with repayment or refinancing expected before maturity.

  • Merger-Related Costs Surge

    Merger and acquisition-related costs reached $57M year-to-date, up from $6M in the prior year, primarily driven by the proposed AkzoNobel combination. These costs are non-deductible, pushing the effective tax rate higher.


Analysis · AXTA · Industrial Applications And Services

Axalta's Q2 results show modest sales growth but a sharp drop in operating income, driven by $35 million in merger-related costs tied to the pending AkzoNobel combination. The effective tax rate jumped to 24.7% as those costs are non-deductible. The company also prepaid $125 million of term loans, strengthening the balance sheet ahead of the merger. With the shareholder vote just a week away, these results highlight the near-term earnings drag from the deal, even as the underlying business holds steady.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AXTA was trading at $35.32 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.6B. The 52-week trading range was $24.94 to $35.98. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Nov 17, 2026, 8:46 AM EST
Filing Type: 425
Importance Score:
7
Price at Filing: $35.75
Real-time Price: $36.23 info
Change: +$0.480 (+1%) info
Market Cap: $7.755B info
AXTA
Nov 17, 2026, 8:41 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.75
Real-time Price: $36.23 info
Change: +$0.480 (+1%) info
Market Cap: $7.755B info
AXTA
Nov 11, 2026, 2:33 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $37.38
Real-time Price: $36.23 info
Change: -$1.15 (-3%) info
Market Cap: $7.755B info
AXTA
Nov 06, 2026, 1:56 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $36.52
Real-time Price: $36.23 info
Change: -$0.290 (-0.79%) info
Market Cap: $7.755B info
AXTA
Nov 06, 2026, 11:15 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $36.40
Real-time Price: $36.23 info
Change: -$0.170 (-0.47%) info
Market Cap: $7.755B info